These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 19915048)
1. Peroxisome proliferator-activated receptor gamma ligands enhance human B cell antibody production and differentiation. Garcia-Bates TM; Baglole CJ; Bernard MP; Murant TI; Simpson-Haidaris PJ; Phipps RP J Immunol; 2009 Dec; 183(11):6903-12. PubMed ID: 19915048 [TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptor γ B cell-specific-deficient mice have an impaired antibody response. Ramon S; Bancos S; Thatcher TH; Murant TI; Moshkani S; Sahler JM; Bottaro A; Sime PJ; Phipps RP J Immunol; 2012 Nov; 189(10):4740-7. PubMed ID: 23041568 [TBL] [Abstract][Full Text] [Related]
3. The PPARgamma ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines. Morosetti R; Servidei T; Mirabella M; Rutella S; Mangiola A; Maira G; Mastrangelo R; Koeffler HP Int J Oncol; 2004 Aug; 25(2):493-502. PubMed ID: 15254749 [TBL] [Abstract][Full Text] [Related]
4. 9-cis-retinoic acid up-regulates expression of transcriptional coregulator PELP1, a novel coactivator of the retinoid X receptor alpha pathway. Singh RR; Gururaj AE; Vadlamudi RK; Kumar R J Biol Chem; 2006 Jun; 281(22):15394-404. PubMed ID: 16574651 [TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor gamma and retinoid X receptor ligands are potent inducers of differentiation and apoptosis in leukemias. Konopleva M; Elstner E; McQueen TJ; Tsao T; Sudarikov A; Hu W; Schober WD; Wang RY; Chism D; Kornblau SM; Younes A; Collins SJ; Koeffler HP; Andreeff M Mol Cancer Ther; 2004 Oct; 3(10):1249-62. PubMed ID: 15486192 [TBL] [Abstract][Full Text] [Related]
6. Ligand-Dependent Corepressor (LCoR) Is a Rexinoid-Inhibited Peroxisome Proliferator-Activated Receptor γ-Retinoid X Receptor α Coactivator. Shalom-Barak T; Liersemann J; Memari B; Flechner L; Devor CE; Bernardo TM; Kim S; Matsumoto N; Friedman SL; Evans RM; White JH; Barak Y Mol Cell Biol; 2018 May; 38(9):. PubMed ID: 29463649 [TBL] [Abstract][Full Text] [Related]
7. Derivation of a retinoid X receptor scaffold from peroxisome proliferator-activated receptor gamma ligand 1-Di(1H-indol-3-yl)methyl-4-trifluoromethylbenzene. Dawson MI; Ye M; Cao X; Farhana L; Hu QY; Zhao Y; Xu LP; Kiselyuk A; Correa RG; Yang L; Hou T; Reed JC; Itkin-Ansari P; Levine F; Sanner MF; Fontana JA; Zhang XK ChemMedChem; 2009 Jul; 4(7):1106-19. PubMed ID: 19378296 [TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor gamma-mediated NF-kappa B activation and apoptosis in pre-B cells. Schlezinger JJ; Jensen BA; Mann KK; Ryu HY; Sherr DH J Immunol; 2002 Dec; 169(12):6831-41. PubMed ID: 12471115 [TBL] [Abstract][Full Text] [Related]
9. Transactivation of the PPAR-responsive enhancer module in chemopreventive glutathione S-transferase gene by the peroxisome proliferator-activated receptor-gamma and retinoid X receptor heterodimer. Park EY; Cho IJ; Kim SG Cancer Res; 2004 May; 64(10):3701-13. PubMed ID: 15150131 [TBL] [Abstract][Full Text] [Related]
10. 9-cis-Retinoic acid (9cRA), a retinoid X receptor (RXR) ligand, exerts immunosuppressive effects on dendritic cells by RXR-dependent activation: inhibition of peroxisome proliferator-activated receptor gamma blocks some of the 9cRA activities, and precludes them to mature phenotype development. Zapata-Gonzalez F; Rueda F; Petriz J; Domingo P; Villarroya F; de Madariaga A; Domingo JC J Immunol; 2007 May; 178(10):6130-9. PubMed ID: 17475839 [TBL] [Abstract][Full Text] [Related]
11. Selective activation of PPARgamma in breast, colon, and lung cancer cell lines. Allred CD; Kilgore MW Mol Cell Endocrinol; 2005 May; 235(1-2):21-9. PubMed ID: 15866424 [TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor gamma ligands stimulate myeloid differentiation and lipogenensis in human leukemia NB4 cells. Yasugi E; Horiuchi A; Uemura I; Okuma E; Nakatsu M; Saeki K; Kamisaka Y; Kagechika H; Yasuda K; Yuo A Dev Growth Differ; 2006 Apr; 48(3):177-88. PubMed ID: 16573735 [TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor gamma transcriptional regulation is involved in platelet-derived growth factor-induced proliferation of human hepatic stellate cells. Galli A; Crabb D; Price D; Ceni E; Salzano R; Surrenti C; Casini A Hepatology; 2000 Jan; 31(1):101-8. PubMed ID: 10613734 [TBL] [Abstract][Full Text] [Related]
14. Synergistic antitumor effect of the activated PPARgamma and retinoid receptors on human osteosarcoma. He BC; Chen L; Zuo GW; Zhang W; Bi Y; Huang J; Wang Y; Jiang W; Luo Q; Shi Q; Zhang BQ; Liu B; Lei X; Luo J; Luo X; Wagner ER; Kim SH; He CJ; Hu Y; Shen J; Zhou Q; Rastegar F; Deng ZL; Luu HH; He TC; Haydon RC Clin Cancer Res; 2010 Apr; 16(8):2235-45. PubMed ID: 20371684 [TBL] [Abstract][Full Text] [Related]
15. [Effects of hexabromocyclododecanes on retinoid X receptor α, pregnane X receptor and peroxisome proliferator-activated receptor γ]. Wan K; Jiang Y; Zhang J; Wang X; Lei Y; Li Y; Xiao Y; Mei S; Zhou J Wei Sheng Yan Jiu; 2017 May; 46(3):396-403. PubMed ID: 29903249 [TBL] [Abstract][Full Text] [Related]
17. Protection against influenza-induced Acute Lung Injury (ALI) by enhanced induction of M2a macrophages: possible role of PPARγ/RXR ligands in IL-4-induced M2a macrophage differentiation. Gopalakrishnan A; Joseph J; Shirey KA; Keegan AD; Boukhvalova MS; Vogel SN; Blanco JCG Front Immunol; 2022; 13():968336. PubMed ID: 36052067 [TBL] [Abstract][Full Text] [Related]
18. Activation of peroxisome proliferator-activated receptor gamma inhibits interleukin-1beta-induced membrane-associated prostaglandin E2 synthase-1 expression in human synovial fibroblasts by interfering with Egr-1. Cheng S; Afif H; Martel-Pelletier J; Pelletier JP; Li X; Farrajota K; Lavigne M; Fahmi H J Biol Chem; 2004 May; 279(21):22057-65. PubMed ID: 15023995 [TBL] [Abstract][Full Text] [Related]
19. Suppression of pancreatic carcinoma growth by activating peroxisome proliferator-activated receptor gamma involves angiogenesis inhibition. Dong YW; Wang XP; Wu K World J Gastroenterol; 2009 Jan; 15(4):441-8. PubMed ID: 19152448 [TBL] [Abstract][Full Text] [Related]
20. Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in human transitional bladder cancer and its role in inducing cell death. Guan YF; Zhang YH; Breyer RM; Davis L; Breyer MD Neoplasia; 1999 Oct; 1(4):330-9. PubMed ID: 10935488 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]